BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21933396)

  • 1. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.
    Curtis JR; Baddley JW; Yang S; Patkar N; Chen L; Delzell E; Mikuls TR; Saag KG; Singh J; Safford M; Cannon GW
    Arthritis Res Ther; 2011; 13(5):R155. PubMed ID: 21933396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining a Claims-based Algorithm to Estimate Biologic Medication Effectiveness and Cost per Effectively Treated Patient with Rheumatoid Arthritis.
    Popp RA; Rascati K; Davis M; Patel U
    Pharmacotherapy; 2018 Feb; 38(2):172-180. PubMed ID: 29197108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments.
    Kim SY; Solomon DH
    Arthritis Res Ther; 2011; 13(5):129. PubMed ID: 21996148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured population.
    Curtis JR; Chastek B; Becker L; Quach C; Harrison DJ; Yun H; Joseph GJ; Collier DH
    J Manag Care Spec Pharm; 2015 Apr; 21(4):318-29. PubMed ID: 25803765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
    Chung CP; Rohan P; Krishnaswami S; McPheeters ML
    Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis.
    Bonafede M; Johnson BH; Princic N; Shah N; Harrison DJ
    J Med Econ; 2015 May; 18(5):376-89. PubMed ID: 25530318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis.
    Grabner M; Boytsov NN; Huang Q; Zhang X; Yan T; Curtis JR
    Arthritis Res Ther; 2017 May; 19(1):92. PubMed ID: 28506320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity.
    Sauer BC; Teng CC; Accortt NA; Burningham Z; Collier D; Trivedi M; Cannon GW
    Arthritis Res Ther; 2017 May; 19(1):86. PubMed ID: 28482933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.
    Curtis JR; Schabert VF; Harrison DJ; Yeaw J; Korn JR; Quach C; Yun H; Joseph GJ; Collier DH
    Clin Ther; 2014 Jul; 36(7):996-1004. PubMed ID: 25012729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study.
    Ng B; Aslam F; Petersen NJ; Yu HJ; Suarez-Almazor ME
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1490-6. PubMed ID: 22623324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis.
    Curtis JR; Schabert VF; Yeaw J; Korn JR; Quach C; Harrison DJ; Yun H; Joseph GJ; Collier D
    J Med Econ; 2014 Aug; 17(8):555-66. PubMed ID: 24754646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis.
    Chastek B; Becker LK; Chen CI; Mahajan P; Curtis JR
    J Med Econ; 2017 May; 20(5):464-473. PubMed ID: 28010149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.
    Cannon GW; Mikuls TR; Hayden CL; Ying J; Curtis JR; Reimold AM; Caplan L; Kerr GS; Richards JS; Johnson DS; Sauer BC
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1680-90. PubMed ID: 21905260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-modifying antirheumatic drug initiation among patients newly diagnosed with rheumatoid arthritis.
    Bonafede M; Johnson BH; Shah N; Harrison DJ; Tang D; Stolshek BS
    Am J Manag Care; 2018 Jul; 24(8 Spec No.):SP279-SP285. PubMed ID: 30020740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival.
    England BR; Sayles H; Michaud K; Thiele GM; Poole JA; Caplan L; Sauer BC; Cannon GW; Reimold A; Kerr GS; Baker JF; Mikuls TR
    Clin Rheumatol; 2018 Nov; 37(11):2907-2915. PubMed ID: 30280369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection.
    Burton MJ; Curtis JR; Yang S; Chen L; Singh JA; Mikuls TR; Winthrop KL; Baddley JW
    J Rheumatol; 2017 May; 44(5):565-570. PubMed ID: 28250142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database.
    Cho SK; Sung YK; Choi CB; Kwon JM; Lee EK; Bae SC
    Rheumatol Int; 2013 Dec; 33(12):2985-92. PubMed ID: 23918169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study.
    Ting G; Schneeweiss S; Scranton R; Katz JN; Weinblatt ME; Young M; Avorn J; Solomon DH
    Arthritis Res Ther; 2008; 10(4):R95. PubMed ID: 18717997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis.
    Shafrin J; Ganguli A; Gonzalez YS; Shim JJ; Seabury SA
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1472-1481. PubMed ID: 27882832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.